Who owns the MAXIMIZE HQ trademark?

The MAXIMIZE HQ trademark is owned by Phase4 Pharmaceutical, LLC.

What class is the MAXIMIZE HQ trademark registered in?

The MAXIMIZE HQ trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations).

What is the serial number for MAXIMIZE HQ?

The USPTO serial number for MAXIMIZE HQ is 98641164.

What is the registration number for MAXIMIZE HQ?

MAXIMIZE HQ is registered under USPTO registration number 7911956.

MAX

USPTO Trademark Record

REGISTERED

MAXIMIZE HQ

SN 98641164·Reg 7911956·Filed Jul 10, 2024

Owner Phase4 Pharmaceutical, LLC

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.

MAXIMIZE HQ (Serial No. 98641164), Registration No. 7911956, is a registered US trademark filed on Jul 10, 2024 by Phase4 Pharmaceutical, LLC. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations).

early section 8: August 26, 2031

Mark Intelligence

MAXIMIZE HQ (Reg. #7911956) is a registered US trademark that has been protecting its owner, Phase4 Pharmaceutical, LLC, since 2024. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations). Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 1 opposition proceeding during prosecution.

FILED

Jul 10, 2024

SERIAL

98641164

REG#

7911956

REGISTERED

Aug 26, 2025

Owner

Applicant

Phase4 Pharmaceutical, LLC

Entity

LLC

State

Address

320 Torchwood Avenue, Plantation, FL, 33324

Country

Attorney

NameAndrew S. Rapacke

Law firm

Andrew S. Rapacke Rapacke Law Group

Address

3750 Birch Terrace, Davie, FL 33330, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateJul 10, 2024

Serial Number98641164

Registration No.7911956

Registration DateAug 26, 2025

Status DateAug 26, 2025

Published for OppositionJun 10, 2025

Mark TypeDesign with words

Status DescriptionLive and registered

Filing Signals

FILED

2024

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 1× during prosecution

Search 15M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

First use anywhere: Jan 01, 2014

First use in commerce: Jan 01, 2014

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

16 events

REGISTERED-PRINCIPAL REGISTER

Aug 26, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Aug 26, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Jun 10, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 10, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 04, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 09, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 08, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 08, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

May 08, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Feb 08, 2025

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Feb 08, 2025

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 08, 2025

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Feb 01, 2025

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 31, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NOTICE OF DESIGN SEARCH CODE E-MAILED

Jan 31, 2025

NOTICE OF DESIGN SEARCH CODE E-MAILED

NEW APPLICATION ENTERED

Jul 10, 2024

NEW APPLICATION ENTERED

MAXIMIZE HQ

Get pre-filing clearance

Search 15M+ trademarks

Run a conflict check

Other Marks by Phase4 Pharmaceutical, LLC

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Andrew S. Rapacke

Resources

Company